BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 34549863)

  • 1. Regulated lytic cell death in breast cancer.
    Liu M; Wang L; Xia X; Wu Y; Zhu C; Duan M; Wei X; Hu J; Lei L
    Cell Biol Int; 2022 Jan; 46(1):12-33. PubMed ID: 34549863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies.
    Woo Y; Lee HJ; Jung YM; Jung YJ
    Cells; 2020 Dec; 9(12):. PubMed ID: 33348858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell death in head and neck cancer pathogenesis and treatment.
    Raudenská M; Balvan J; Masařík M
    Cell Death Dis; 2021 Feb; 12(2):192. PubMed ID: 33602906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Regulated Cell Death with Pharmacological Small Molecules: An Update on Autophagy-Dependent Cell Death, Ferroptosis, and Necroptosis in Cancer.
    Wu J; Ye J; Xie Q; Liu B; Liu M
    J Med Chem; 2022 Feb; 65(4):2989-3001. PubMed ID: 35130435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging role of necroptosis, pyroptosis, and ferroptosis in breast cancer: New dawn for overcoming therapy resistance.
    Fu B; Lou Y; Wu P; Lu X; Xu C
    Neoplasia; 2024 Jun; 55():101017. PubMed ID: 38878618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lytic cell death in metabolic liver disease.
    Gautheron J; Gores GJ; Rodrigues CMP
    J Hepatol; 2020 Aug; 73(2):394-408. PubMed ID: 32298766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.
    Tang R; Xu J; Zhang B; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
    J Hematol Oncol; 2020 Aug; 13(1):110. PubMed ID: 32778143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting regulated cell death (RCD) in hematological malignancies: Recent advances and therapeutic potential.
    Zhang Y; Zhou X
    Biomed Pharmacother; 2024 Jun; 175():116667. PubMed ID: 38703504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
    Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
    J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer.
    Zhang C; Liu N
    Front Immunol; 2022; 13():920059. PubMed ID: 35958626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies.
    Liao M; Qin R; Huang W; Zhu HP; Peng F; Han B; Liu B
    J Hematol Oncol; 2022 Apr; 15(1):44. PubMed ID: 35414025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alkaloid, soyauxinium chloride, displays remarkable cytotoxic effects towards a panel of cancer cells, inducing apoptosis, ferroptosis and necroptosis.
    Mbaveng AT; Noulala CGT; Samba ARM; Tankeo SB; Abdelfatah S; Fotso GW; Happi EN; Ngadjui BT; Beng VP; Kuete V; Efferth T
    Chem Biol Interact; 2021 Jan; 333():109334. PubMed ID: 33245930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting regulated cell death in tumor nanomedicines.
    Zeng Q; Ma X; Song Y; Chen Q; Jiao Q; Zhou L
    Theranostics; 2022; 12(2):817-841. PubMed ID: 34976215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell death-mediated cytokine release and its therapeutic implications.
    Place DE; Kanneganti TD
    J Exp Med; 2019 Jul; 216(7):1474-1486. PubMed ID: 31186281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heme Oxgenase-1, a Cardinal Modulator of Regulated Cell Death and Inflammation.
    Ryter SW
    Cells; 2021 Feb; 10(3):. PubMed ID: 33671004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PANoptosis: a potential new target for programmed cell death in breast cancer treatment and prognosis.
    Liu X; Miao M; Sun J; Wu J; Qin X
    Apoptosis; 2024 Apr; 29(3-4):277-288. PubMed ID: 38001342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroptosis, necroptosis, and pyroptosis in cancer: Crucial cell death types in radiotherapy and post-radiotherapy immune activation.
    Wang Y; Wang Y; Pan J; Gan L; Xue J
    Radiother Oncol; 2023 Jul; 184():109689. PubMed ID: 37150447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted regulated cell death with small molecule compounds in colorectal cancer: Current perspectives of targeted therapy and molecular mechanisms.
    Li R; Wu Y; Li Y; Shuai W; Wang A; Zhu Y; Hu X; Xia Y; Ouyang L; Wang G
    Eur J Med Chem; 2024 Feb; 265():116040. PubMed ID: 38142509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell death, therapeutics, and the immune response in cancer.
    Hänggi K; Ruffell B
    Trends Cancer; 2023 May; 9(5):381-396. PubMed ID: 36841748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging roles of nitric oxide in ferroptosis and pyroptosis of tumor cells.
    He Q; Qu M; Xu C; Shi W; Hussain M; Jin G; Zhu H; Zeng LH; Wu X
    Life Sci; 2022 Feb; 290():120257. PubMed ID: 34952041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.